• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

WellPoint acquires Resolution Health

Article

WellPoint Inc.’s acquisition of Resolution Health Inc., a data analytics-driven personal healthcare guidance company, is yet another reflection of the interest in consumer-driven tools such as EHRs, PHRs, and health-related search engines, among others.

WellPoint Inc.’s acquisition of Resolution Health Inc., a data analytics-driven personal healthcare guidance company, is yet another reflection of the interest in consumer-driven tools such as EHRs, PHRs, and health-related search engines, among others.

“Personalized medical communication is exactly what we are trying to accomplish in healthcare,” Dijuana Lewis, chief executive of WellPoint’s Comprehensive Health Solutions business unit, tells Managed Healthcare Executive. “By tailoring healthcare recommendations to individual WellPoint members, and sometimes doctors, we can reach people before they get really sick or have an adverse event.”

Resolution Health’s Earl Steinberg, MD, co-founder and CEO says collecting data from insurance claims, health records and other medical and pharmacy reports “allows us to paint what we call a total patient picture. The more types of data we’re able to get access to, the more colorful that picture.”

Approximately two years ago, the pair announced a strategic alliance to help improve members’ compliance with care recommendations and reduce out-of-pocket expenses through personalized communications that empower members to take greater control of their health and healthcare decision making.

Terms of this deal have not been disclosed.

In other WellPoint news, the insurer, in close collaboration with leading government and academic institutions, including the FDA and faculty from key academic institutions, including Harvard University, the University of North Carolina and the University of Pennsylvania, has announced the development of a system to more effectively and rapidly monitor the safety of pharmaceuticals and other medical therapies after FDA approval. Starting next year, the Safety Sentinel System is expected to be capable of continually monitoring WellPoint’s 35-million member database and identifying increases in health problems among members taking a given drug, indicating a potential Serious Adverse Event (SAE).  It is anticipated that the System will also make it possible to examine whether particular combinations of treatments could cause serious medical problems, especially in patients with certain diseases or health conditions.

Related Videos
Video 9 - "Denial of Coverage in Fertility Care"
Video 8 - "Risks of Miscarriage and Multiple Births Associated with Fertility Care"
Video 7 - "Fertility Preservation: Egg Freezing Versus Embryo Freezing"
Video 6 - "Family Building Costs, Barriers, and Dropout Rates Associated with Fertility Care"
Video 5 - "Closing Payer Gaps and Improving Fertility Care Access"
Video 4 - "Increasing Employer Coverage and Maximizing Fertility Benefits "
Video 5 - "Relevance of NUTURE Study Findings for Patients, Payers, Providers"
Video 3 - "Improving IVF Success Rates & Utilizing AI in Fertility Health Care"
Video 2 - "Holistic Fertility Management and Payer Collaboration"
Video 5 - "Relevance of NUTURE Study Findings for Patients, Payers, Providers"
Related Content
© 2024 MJH Life Sciences

All rights reserved.